Addressing Drop Adherence

Show Description +

I. Paul Singh, MD, describes the use of iStent Infinite (Glaukos) and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) to help reduce the drop burden for this patient.

Financial disclosure: Consultant (Glaukos)

Posted: 1/02/2024

Addressing Drop Adherence

I. Paul Singh, MD, describes the use of iStent Infinite (Glaukos) and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) to help reduce the drop burden for this patient.

Financial disclosure: Consultant (Glaukos)

Posted: 1/02/2024

Please log in to leave a comment.

More in Glaucoma

The Blind Truth: Too Many Glaucoma Patients Are Lost to Care

J. Morgan Micheletti, MD; and Andrew Williams, MD

Academy IRIS® Registry Data Outcomes on Gel Stent Use

Arsham Sheybani, MD

A Monocular Patient With Significant OSD and Worsening Visual Acuity

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO